MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET

Xiu-Jie Sheng1, Zhen Li1, Man Sun1

  • 1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China.

Oncology Letters
|July 11, 2014
PubMed

Insights

Metastasis-associated in colon cancer 1 (MACC1) gene silencing reduced ovarian cancer cell invasion and metastasis. MACC1 targets c-MET, suggesting MACC1 inhibition as a potential ovarian cancer treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastasis-associated in colon cancer 1 (MACC1) is implicated in tumor invasion and metastasis.
  • Ovarian cancer progression involves complex cellular mechanisms including invasion and metastasis.

Purpose of the Study:

  • To investigate the functional role of MACC1 in ovarian cancer.
  • To determine the effect of MACC1 downregulation on OVCAR3 cell biological characteristics.
  • To explore the relationship between MACC1 and the c-MET gene.

Main Methods:

  • RNA interference (siRNA) was used to downregulate MACC1 expression in OVCAR3 cells.
  • Quantitative PCR and Western blot confirmed MACC1 knockdown.
  • Cell proliferation, adhesion, invasion, migration, angiogenesis, and c-MET interaction were assessed.

Main Results:

  • MACC1 downregulation significantly reduced ovarian cancer cell invasion, migration, and angiogenesis.
  • MACC1 inhibition had minimal impact on cell proliferation and adhesion.
  • MACC1 was confirmed to target and reduce c-MET protein expression.

Conclusions:

  • MACC1 downregulation suppresses ovarian cancer cell invasion and metastasis.
  • MACC1 regulates cancer cell metastasis potentially by targeting c-MET.
  • Inhibiting MACC1 function presents a novel therapeutic strategy for ovarian cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K